ArticleJournal of the American Society of Nephrology : JASN2026
Hmx2 and Dmrt2 Coordinate the Differentiation of Intercalated Cell Subtypes in Kidney.
Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Kidney Cyst Epithelia in Tuberous Sclerosis Complex (TSC) Exhibit Propagation and Expansion of A-Intercalated, but Loss of B-Intercalated and Principal Cells: The Role of FOXI1, FOXP1, and DMRT2 Transcription Factors.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
key pointsHmx2 was required for type B intercalated cell differentiation but became dispensable in the absence of Dmrt2. Dmrt2 promoted type A differentiation of intercalated cells and repressed type B identity. Early divergence of Dmrt2 and Hmx2 marked subtype specification of intercalated cells.
backgroundIntercalated cells in the kidney collecting ducts are essential for maintaining systemic acid-base homeostasis. Based on gene expression profiles and functional characteristics, intercalated cells are classified into type A, type B, non-A/non-B. Although several transcription factors have been reported to regulate intercalated cell differentiation, how the fates of intercalated cell subtypes are established remains unclear.
methodsTo investigate the roles of Dmrt2 and Hmx2 in intercalated cell subtype differentiation, we generated mice with single or double conditional deletion and knock-in of these transcription factors specifically in distal nephron segments and analyzed their effects on urine acidification. We also performed single-cell RNA sequencing analysis on mouse and human kidney datasets to trace intercalated cell progenitor fate trajectories.
resultsLoss of Hmx2 in the distal nephron prevented type B intercalated cell differentiation, whereas simultaneous deletion of Hmx2 and Dmrt2 compromised type A intercalated cell differentiation, with a concomitant increase in Hmx3 expression and type B intercalated cell differentiation. Dmrt2 knock-in mice exhibited a modest increase in type A intercalated cell differentiation and a marked reduction in type B intercalated cells. Notably, Dmrt2 knock-in did not rescue the intercalated cell differentiation defects observed in Foxp1-deficient mice. Analysis of mouse and human single-cell RNA sequencing data further confirmed the mutually exclusive expression patterns of Hmx2 and Dmrt2 in the kidney.
conclusionsHmx2 and Dmrt2 were essential, mutually exclusive transcription factors that govern intercalated cell subtype differentiation in the kidney, with Hmx2 specifying type B intercalated cell fate and Dmrt2 promoting type A intercalated cell differentiation. Dmrt2 suppressed the expression of Hmx2 and Hmx3. In the absence of Dmrt2 and Hmx2, Hmx3 expression was activated to promote type B intercalated cell differentiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.